The US Bioresorbable Polymers Market Size was estimated at 237 (USD Million) in 2023. The US Bioresorbable Polymers Industry is expected to grow from 238.5(USD Million) in 2024 to 1,006.5 (USD Million) by 2035. The US Bioresorbable Polymers Market CAGR (growth rate) is expected to be around 13.985% during the forecast period (2025 - 2035).
In the US Bioresorbable Polymers Market, key market drivers include an increasing demand in the medical sector, particularly due to the rise in minimally invasive surgeries and orthopedic procedures. Organizations such as the U.S. Food and Drug Administration (FDA) support the development of bioresorbable materials for medical devices, which drives innovation in this sector. Additionally, advancements in technology related to polymer synthesis and processing enhance the functionality and applicability of these materials, making them more appealing to healthcare providers. There are significant opportunities to be explored, particularly in the areas of drug delivery systems and tissue engineering.The growing trend of personalized medicine creates a niche market for bioresorbable polymers that can be tailored for specific patients or treatment protocols. Collaborations between biotechnology firms and research institutions are also paving the way for novel applications, leading to increased investment in bioresorbable polymers. Recent trends show a heightened awareness and demand for sustainable products, urging manufacturers in the US to focus on eco-friendly bioresorbable options. This shift reflects a broader commitment to environmental sustainability within the healthcare sector. Increased regulatory support is also evident; this encourages the use of bioresorbable polymers across various applications, from sutures to implants.Innovations in material characteristics and the push towards eco-conscious solutions are significant forces shaping the direction of the US Bioresorbable Polymers Market in the near future.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Increasing Demand for Minimally Invasive Surgical Procedures
The shift toward minimally invasive surgical procedures in the United States is a significant driver for the US Bioresorbable Polymers Market Industry. Innovative surgical practices are increasingly favored due to their associated benefits such as reduced recovery time, lower risk of infection, and decreased scarring. According to the American Society for Gastrointestinal Endoscopy, procedures performed with minimally invasive techniques grew by over 30% in the past decade, with an increasing number projected in various surgical specialties.As hospitals and clinics transition to these advanced techniques, the demand for bioresorbable polymers is anticipated to rise, predominantly because they support surgical operations with materials that eliminate the need for additional surgery to remove implants. Major medical device companies such as Medtronic and Boston Scientific are investing heavily in bioresorbable technologies to cater to this growing market and address evolving surgical needs.
Rising Prevalence of Chronic Diseases
The prevalence of chronic diseases such as cardiovascular disorders, diabetes, and orthopedic conditions is rising in the United States, driving demand for bioresorbable polymers. The Centers for Disease Control and Prevention (CDC) report that approximately 6 in 10 adults in the US have a chronic disease, and this is projected to increase as the population ages. Bioresorbable polymers play an essential role in providing scaffolding for tissue engineering and organ regeneration, which is critical in treating these diseases effectively.Medical organizations, including the American Heart Association, are actively researching bioresorbable materials for applications in stents and surgical implants, highlighting the growing intersection between healthcare needs and innovative materials. The consistent push from healthcare professionals toward finding efficient and effective solutions signifies a robust market potential for bioresorbable polymers in the realm of chronic disease management.
Technological Advancements in Medical Devices
Continuous advancements in medical device technology are a key driver for the US Bioresorbable Polymers Market Industry. The National Institutes of Health (NIH) have facilitated numerous grants and funding opportunities for Research and Development (R&D) focusing on biomaterials, which significantly boosts innovations in the use of bioresorbable polymers. The implementation of advanced 3D printing technology and bioengineering techniques are leading to novel applications in the medical field, as highlighted in the NIH's annual funding reports, which show an almost 20% increase in funding dedicated to this specific area over the last five years.Organizations like the Food and Drug Administration (FDA) are also encouraging the integration of bioresorbable materials in device approvals, noting that they can improve patient outcomes by reducing long-term complications associated with permanent implants. This synergy between innovation and regulatory support significantly enhances the market outlook for bioresorbable polymers in medical devices.
The US Bioresorbable Polymers Market is witnessing robust growth driven by increasing applications in healthcare, particularly in drug delivery systems, sutures, and tissue engineering. The Type segment comprises notable categories such as Agro-Polymers and Bio-Polyesters, which are gaining recognition for their sustainable benefits and versatility. Agro-Polymers, derived from natural resources, are increasingly used in agricultural applications, including biodegradable films and seed coatings, aiding in sustainable farming practices. Their ability to reduce plastic accumulation in soil makes them significant in addressing environmental concerns.On the other hand, Bio-Polyesters are extensively utilized in medical devices and packaging, highlighting their role in converting traditional petroleum-based products to more eco-friendly solutions. Given the rising consumer awareness regarding environmental sustainability and government regulations favoring biodegradable materials, the significance of these materials in the US market is further amplified. The US Bioresorbable Polymers Market is experiencing dynamic changes and trends, with a focus on enhancing product functionality while minimizing environmental impact, thus paving the way for further innovations in these types.Consequently, both Agro-Polymers and Bio-Polyesters not only contribute to significant industrial shifts but also support the overall growth trajectory of the US Bioresorbable Polymers Market, positioning them as vital components in the future of material science and sustainability initiatives.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The US Bioresorbable Polymers Market showcases a diverse application landscape, significantly impacting various sectors such as Orthopedic, Drug Delivery, Biodegradable Devices, and others. Orthopedic applications stand out with innovative solutions that enhance patient recovery by providing temporary support while minimizing complications associated with traditional implants. In Drug Delivery, the growth is driven by the ability of bioresorbable materials to provide controlled release of therapeutics, simplifying complex therapies and improving patient compliance.Biodegradable Devices, leveraging the environmental benefits of bioresorbable materials, align well with the increasing emphasis on sustainability in healthcare. Additionally, the exploration of other applications highlights the versatile nature of these polymers, catering to niche and emerging markets. Together, these factors contribute positively to the US Bioresorbable Polymers Market statistics, driven by advancements in technology and rising demand for patient-centric solutions. This segmentation emphasizes the importance of bioresorbable polymers in enhancing medical outcomes and showcasing the industry's growth potential in the coming years, backed by ongoing research and development initiatives across the US.
The competitive landscape of the US Bioresorbable Polymers Market is characterized by a dynamic interplay of innovation, technological advancements, and strategic partnerships among various key players. Bioresorbable polymers are gaining traction primarily due to their potential applications in medical devices, drug delivery systems, and tissue engineering. Companies within this segment are increasingly focusing on developing advanced materials that are not only effective in their functionality but also meet stringent regulatory standards. The market is witnessing a surge in research and development efforts aimed at enhancing the properties of bioresorbable polymers, which cater to specific applications in the healthcare sector. This has led to an evolving competitive framework where companies are striving to leverage their technological capabilities and expertise to gain a competitive edge.BASF holds a significant position within the US Bioresorbable Polymers Market, with a strong emphasis on innovation and product development. The company leverages its extensive research capabilities and advanced polymer technology to create sophisticated solutions that cater to the demands of the healthcare industry. BASF's strengths lie in its deep knowledge of polymer chemistry and extensive manufacturing capabilities, enabling it to produce high-quality bioresorbable materials that fulfill various medical applications. The company's strategic collaborations with research institutions and healthcare companies further bolster its market presence, as these partnerships allow BASF to expand its product portfolio and enter new market segments while maintaining a focus on sustainable practices.Boehringer Ingelheim has established itself as a formidable player in the US Bioresorbable Polymers Market through its commitment to innovation and comprehensive product offerings. The company is recognized for its advanced bioresorbable polymer products that are primarily utilized in pharmaceuticals and medical devices, enabling effective drug delivery and enhanced therapeutic outcomes. Boehringer Ingelheim's strengths include its robust research and development pipeline, which is aimed at advancing drug formulation technologies and enhancing patient safety. The company’s strategic mergers and acquisitions have further fortified its market position, allowing it to integrate cutting-edge technologies and expand its capabilities within the bioresorbable sector. By focusing on quality and innovation while fostering collaborations with key stakeholders, Boehringer Ingelheim continues to strengthen its prominence within the US market.
The US Bioresorbable Polymers Market has seen notable developments recently. For instance, in January 2023, Medtronic announced advancements in its research initiatives focusing on bioresorbable materials aimed at enhancing patient recovery times. Various companies, including BASF and Evonik Industries, are increasing their investments in Research and Development to support the growing demand for biocompatible and sustainable materials in medical applications. Furthermore, PolyMedicure has expanded its product offerings, targeting the cardiovascular sector, capitalizing on the shift towards minimally invasive procedures.In terms of mergers and acquisitions, March 2023 marked a significant acquisition by Boehringer Ingelheim, which purchased a smaller biotech firm to strengthen its portfolio in regenerative medicine, including bioresorbable technologies. The US Bioresorbable Polymers Market is projected to grow, driven by advancements and increasing applications in medical devices, particularly in orthopedics and cardiology. Moreover, the recent emphasis on sustainability and eco-friendliness is influencing the development of bioresorbable materials across the industry. Noteworthy events in the last two to three years include the launch of innovative products by Sientra in June 2021 that further propelled the market's expansion.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 237.0(USD Million) |
| MARKET SIZE 2024 | 238.5(USD Million) |
| MARKET SIZE 2035 | 1006.5(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 13.985% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | BASF, Boehringer Ingelheim, Synlogic, PolyMedicure, Sientra, Tetracore, Solvay, Fuzhou Huachang, Galmed Pharmaceuticals, Reva Medical, Rochester Institute of Technology, Medtronic, Corbion, Evonik Industries |
| SEGMENTS COVERED | Type, Application |
| KEY MARKET OPPORTUNITIES | Increasing demand in medical applications, Growing focus on sustainable materials, Expanding pharmaceutical and biotech sectors, Advancements in polymer technology, Rising awareness of environmental impact |
| KEY MARKET DYNAMICS | sustainable materials demand, regulatory approvals impact, technological advancements driving innovation, increasing healthcare applications, rising consumer awareness |
| COUNTRIES COVERED | US |
Frequently Asked Questions (FAQ) :
The US Bioresorbable Polymers Market is expected to be valued at 238.5 million USD in 2024.
By 2035, the market is projected to reach a value of 1006.5 million USD.
The expected CAGR for the market from 2025 to 2035 is 13.985 percent.
The primary types of bioresorbable polymers are Agro-Polymers and Bio-Polyesters.
In 2024, the market value of Agro-Polymers is 70.0 million USD.
The market value of Bio-Polyesters in 2024 is expected to be 168.5 million USD.
The market size for Agro-Polymers is expected to grow to 300.0 million USD by 2035.
By 2035, the projected market size of Bio-Polyesters is 706.5 million USD.
Major players in the market include BASF, Boehringer Ingelheim, and Medtronic.
Key applications include medical devices, drug delivery systems, and tissue engineering.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Research Analyst Level I In her 3 years of experience in the market research field, she has handled critical cross-domain projects. she has an in-depth knowledge of market estimation & analysis, problem-solving, primary as well as secondary research, and team management.she holds an engineering degree and is an mba professional from a well-known university, capable of evaluating the market and competitive conditions. an exceptional strategist with excellent communication skills and a passion for delivering cutting-edge & practical insights for the market. proficient in multi-tasking, and can successfully deal with competing demands, while maintaining complete confidentiality. generated business through active client and project development, networking, and high-quality responses. her knowledge and skills have helped in making solid business decisions, securing funding from investors, and avoiding business failures.
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
